Sirolimus Tablets

Hazard statements (CLP)

H351, H360FD, H402, H412

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

Classification of the substance or mixture GHS - Classification Carcinogenicity Reproductive toxicity Acute aquatic toxicity Chronic aquatic toxicity Category 2 - (H351) Category 1B - (H360FD) Category 3 - (H402) Category 3 - (H412)

Signal word

Danger

Hazard statements

H360FD - May damage fertility. May damage the unborn child H351 - Suspected of causing cancer H412 - Harmful to aquatic life with long lasting effects

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P273 - Avoid release to the environment P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

Other hazards

An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

GHS - Classification Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1B - (H360FD) Acute aquatic toxicity Category 3 - (H402) Chronic aquatic toxicity Category 3 - (H412)